Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020

NASDAQ Market News

NEXT STORY
Fluidigm Mass Cytometry Technologies, Including CyTOF, Imaging Mass Cytometry and Maxpar Direct, Utilized in More than 100 National Clinical Trials
PREV STORY
TLC Announces Acceptance of Manuscript on Anti-COVID-19 Program by Clinical and Translational Science Journal
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11

author_avatar
NASDAQ Market News

Nephros Subsidiary Specialty Renal Products and HemoCleanse Announce License Agreement for Dialysate Filtration System

Pioneering HemoCleanse CEO to Join Specialty Renal Products Board of Directors SOUTH ORANGE, NJ, ...

author_avatar
NASDAQ Market News

Aptevo Therapeutics Reports Continued Progress In APVO210 and APVO436 Clinical Trials

author_avatar
NASDAQ Market News